Investor insights
Sectors invested in
Funding rounds participated in
$76M sweet spot round size
Most of their 15 investments are in rounds between $30M and $103M
Investor type
Basic info
Industry
Sectors
Date founded
1993
Investments made
Sonoma Biotherapeutics raised $265M on August 4, 2021
Investors: NS Investment, Lilly Asia Ventures, Piper Sandler, JDRF T1D Fund, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd, Vertex Ventures HC and Octagon Capital
Undercover Chocolate Co. raised $14M on July 21, 2021
Investors: Octagon Capital
Undisclosed raised $80M on March 24, 2021
Investors: Decheng Capital, BlueRun Ventures, Hillhouse Capital Management, Shenzhen Capital Group Co., Ltd and Octagon Capital
Century Therapeutics, Inc raised $160M on March 3, 2021
Investors: Logos Global Management, LP, Qatar Investment Authority, Leaps by Bayer, Versant Ventures, RA Capital Management, L.P., OrbiMed Advisors, Marshall Wace and Octagon Capital
Cullgen Inc. raised $50M on February 25, 2021
Investors: MSA Capital, 3E Bioventures Capital and Octagon Capital
Vera Therapeutics, Inc. raised $80M on January 19, 2021
Investors: Surveyor Capital, GV, Kleiner Perkins, Abingworth, Longitude Capital and Octagon Capital
ImmVira raised undisclosed on December 31, 2020
Investors: 博儒资本, China Merchants Capital, 澜亭资本, Hillhouse Capital Management, OrbiMed Advisors and Octagon Capital
Undisclosed raised $70M on September 30, 2020
Investors: Lilly Asia Ventures, Lifeforce Capital, 8VC, Lyell Immunopharma, JDRF T1D Fund, ARCH Venture Partners and Octagon Capital
Sonoma Biotherapeutics raised $30M on September 30, 2020
Investors: Lilly Asia Ventures, Lyell Immunopharma, JDRF T1D Fund, Lifeforce Capital, 8VC, ARCH Venture Partners and Octagon Capital
I-Mab Biopharma raised $418M on September 4, 2020
Investors: Lake Bleu Capital (Hong Kong) Limited, GIC, Hillhouse Capital Management, Avidity Partners, OrbiMed Advisors, Perceptive Advisors, The Invus Group and Octagon Capital